Essential Guide to Blood Coagulation.

Essential Guide to Blood Coagulation.

Show other versions (1)
Saved in:
Bibliographic Details
Online Access: Full Text (via ProQuest)
Main Author: Antovic, Jovan
Other Authors: Blomb?ck, Margareta
Format: eBook
Language:English
Published: New York : Wiley, 2013.
Edition:2nd ed.
Subjects:
Blood > Coagulation.

MARC

LEADER 00000cam a2200000Mu 4500
001 b9690224
003 CoU
005 20170929044338.7
006 m o d
007 cr |||||||||||
008 130309s2013 nyu ob 001 0 eng d
020 |a 9781118327678 
020 |a 1118327675 
020 |z 9781118288795  |q (pbk. ;  |q alk. paper) 
035 |a (OCoLC)ebqac829459892 
035 |a (OCoLC)829459892 
037 |a ebqac1132829 
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d UKDOC  |d OCLCQ  |d DEBSZ  |d COO  |d OCLCO  |d OCLCF  |d OCLCQ  |d OCLCO  |d Z5A  |d MERUC 
049 |a GWRE 
050 4 |a RC647 .C55 E87 2013 
066 |c (S 
100 1 |a Antovic, Jovan. 
245 1 0 |a Essential Guide to Blood Coagulation. 
250 |a 2nd ed. 
260 |a New York :  |b Wiley,  |c 2013. 
300 |a 1 online resource (218 pages) 
336 |a text  |b txt  |2 rdacontent. 
337 |a computer  |b c  |2 rdamedia. 
338 |a online resource  |b cr  |2 rdacarrier. 
504 |a Includes bibliographical references and index. 
505 0 |a Schematic presentation of the hemostatic system / Nils Egberg -- Proposals for sampling instructions / Margareta Blombäck and Nils Egberg -- Laboratory investigations / Jovan P. Antovic, Liselotte Onelöv, and Nils Egberg -- Hereditary bleeding disorders / Margareta Holmström and Lars-Göran Lundberg -- Critical bleeding / Maria Bruzelius, Anna Ågren, and Hans Johnsson -- Investigation of increased bleeding tendency / Margareta Holmström and Lars Göran Lundberg -- Venous thrombosis and pulmonary embolism / Anders Carlsson -- Investigations of thromboembolic tendency / Margareta Holmström -- Heart disease / Håkan Wallen and Rickard Linder -- Antiplatelet drug therapy and reversal of its effects / Håkan Wallen, Hans Johnsson, and Bo-Michael Bellander -- New oral anticoagulants : focus on currently approved oral factor Xa and thombin inhibitors / Rickard E. Malmström and Hans Johnsson -- Stroke and transient ischemic attack / Nils Wahlgren and Mia von Euler -- Peripheral artery surgery / Jesper Swedenborg -- Hemostasis in obstetrics and gynecology / Katarina Bremme -- Hemostasis in children / Susanna Ranta and Pia Petrini -- Emergency conditions associated with coagulation : DIC, HIT, and TTP/HUS / Jovan P. Antovic and Margareta Holmström. 
588 0 |a Print version record. 
650 0 |a Blood  |x Coagulation. 
650 7 |a Blood  |x Coagulation.  |2 fast  |0 (OCoLC)fst00834568. 
700 1 |a Blomb?ck, Margareta. 
776 0 8 |i Print version:  |a Antovic, Jovan.  |t Essential Guide to Blood Coagulation.  |d New York : Wiley, ©2013  |z 9781118288795. 
856 4 0 |u http://ebookcentral.proquest.com/lib/ucb/detail.action?docID=1132829  |z Full Text (via ProQuest) 
880 0 0 |6 505-00  |t Part 1 General Hemostasis -- --  |g 1.  |t Schematic presentation of the hemostatic system -- --  |g 2.  |t Proposals for sampling instructions --  |t Points to note prior to sampling --  |t Sampling time and patient preparation --  |t Referrals for coagulation analyses --  |t Sampling --  |t Analyses of plasma --  |t Technique --  |t For DNA investigation (genetic analyses) --  |t Reference -- --  |g 3.  |t Laboratory investigations --  |t Nomenclature --  |t Reference intervals for laboratory investigations --  |t Screening analyses --  |t Pt-Bleeding time --  |t Other proposed analyses when bleeding time is increased in spite of normal platelet count --  |t Special analyses --  |t Coagulation factors --  |t Anticoagulants --  |t Protein C anticoagulant system --  |t Platelet function --  |t Fibrinolysis --  |t Markers of coagulation activation (hypercoagulation markers) --  |t Activating peptides: general remarks --  |t P-prothrombin fragment 1+2 (F1+2) --  |t P-thrombin-antithrombin (TAT) complex --  |t DNA analyses --  |t DNA-based diagnosis of hemophilia A and B --  |t DNA-based diagnosis in VWD --  |t DNA-based diagnosis in other hereditary bleeding disorders --  |t DNA-based diagnosis in thromboembolic disorders --  |t Global hemostatic assays and bedside methods --  |t Endogenous thrombin potential (ETP) --  |t Overall hemostatic potential (OHP) --  |t Thromboelastography (TEG®)/ROTEM®) --  |t Point-of-care tests (POCT) also used as a routine --  |t Useful components in research studies --  |t Fibrin-gel structure --  |t P-plasmin-plasmin inhibitor complex --  |t P-t-PA-PAI complex --  |t P-thrombin time --  |t P-ecarin clotting time --  |t P-C1-esterase inhibitor --  |t P-elastase --  |t P-heparin co-factor II (HC II) --  |t P-plasminogen activator inhibitor 2 (PAI-2) --  |t P-protein C inhibitor --  |t P-APC-protein C inhibitor (PCI) complex --  |t P-Tafi --  |t P-VWF cleaving protease = ADAMTS-13 --  |t P-tissue factor pathway inhibitor (TFPI) --  |t P-tissue factor (TF) --  |t Platelet-activating predictors --  |t P-thromboglobulin (β-TG), P-platelet factor 4 (PF4) --  |t Platelet P-selectin (CD62P) or P-soluble P-selectin --  |t PLT-fibrinogen, PLT-VWF --  |t Microparticles (MP) --  |t Other non-hemostatic variables of importance P/S-CRP --  |t Combinations of assays suggested for various hemostatic abnormalities --  |t References --  |t Part 2 Bleeding Disorders -- --  |g 4.  |t Hereditary bleeding disorders --  |t General remarks about hemophilia A and B --  |t General remarks about von Willebrand disease --  |t Factor concentrates used for treatment of hemophilia A and B and VWD in Sweden in 2012 --  |t General remarks about factor concentrates --  |t Treatment strategy in severe forms of hemophilia and VWD --  |t Home/self-treatment --  |t Treatment in trauma and acute bleedings --  |t Recommendations for desired initial plasma concentrations at different types of bleedings --  |t Prophylaxis against joint bleedings --  |t Surgery in patients with bleeding disorders --  |t Tooth extraction in a hemophilia patient --  |t Caution in patients with bleeding disorders --  |t Pain-killing drugs allowed in hemophilia --  |t Other important issues in more severe forms of hemophilia and VWD --  |t Risk of hepatitis --  |t Treatment principles for different types of bleeding disorders (severe, moderate, and milder forms of hemostatic defects) --  |t Hematuria --  |t Nose bleeding --  |t Gum bleeding --  |t Menorrhagia --  |t Pregnancy and delivery --  |t Treatment with tranexamic acid --  |t Contraindication --  |t Rare bleeding disorders --  |t Severe platelet function defect (e.g. Glanzmann thrombasthenia) --  |t Mild hemostatic defects --  |t Blood sampling in bleeding disorders --  |t Bleeding risk charts -- 
907 |a .b96902243  |b 07-02-19  |c 10-03-17 
998 |a web  |b  - -   |c f  |d b   |e z  |f eng  |g nyu  |h 0  |i 1 
956 |a Ebook Central Academic Complete 
956 |b Ebook Central Academic Complete 
999 f f |i dfb3a840-c0ff-5fe3-b581-b86731a96176  |s cc29d2f9-4ec5-514d-a7f2-13d80a29458a 
952 f f |p Can circulate  |a University of Colorado Boulder  |b Online  |c Online  |d Online  |e RC647 .C55 E87 2013  |h Library of Congress classification  |i web  |n 1 

Similar Items